These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

827 related articles for article (PubMed ID: 23047823)

  • 1. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant.
    Leung N; Bridoux F; Hutchison CA; Nasr SH; Cockwell P; Fermand JP; Dispenzieri A; Song KW; Kyle RA;
    Blood; 2012 Nov; 120(22):4292-5. PubMed ID: 23047823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Latest updates on immunotactoid glomerulopathy and fibrillary glomerulonephritis].
    Lafargue MC; Cohen C
    Bull Cancer; 2024; 111(7-8):741-747. PubMed ID: 36803980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal gammopathy: The good, the bad and the ugly.
    Glavey SV; Leung N
    Blood Rev; 2016 May; 30(3):223-31. PubMed ID: 26732417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal Gammopathy of Undetermined Significance: A Comprehensive Review.
    Kaur J; Valisekka SS; Hameed M; Bandi PS; Varma S; Onwughalu CJ; Ibrahim H; Mongia H
    Clin Lymphoma Myeloma Leuk; 2023 May; 23(5):e195-e212. PubMed ID: 36966041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updates in Plasma Cell Dyscrasias and Related Monoclonal Immunoglobulin-Mediated Renal Disease.
    Midha S; Nadeem O; Selamet U
    Semin Nephrol; 2022 Nov; 42(6):151352. PubMed ID: 37257390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-Transplant Monoclonal Gammopathy of Renal Significance: A Case Report.
    Movilla Echeverri C; Montilla Cosano G; Rivera Garrido C; Suñer Poblet M; Suarez Benjumea A
    Transplant Proc; 2023 Dec; 55(10):2301-2303. PubMed ID: 38030424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance.
    Castillo JJ; Callander NS; Baljevic M; Sborov DW; Kumar S
    Am J Hematol; 2021 Jul; 96(7):846-853. PubMed ID: 33709474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal gammopathy of renal significance: Multidisciplinary approach to diagnosis and treatment.
    Karam S; Haidous M; Dalle IA; Dendooven A; Moukalled N; Van Craenenbroeck A; Bazarbachi A; Sprangers B
    Crit Rev Oncol Hematol; 2023 Mar; 183():103926. PubMed ID: 36736510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity.
    Ciocchini M; Arbelbide J; Musso CG
    Int Urol Nephrol; 2017 Dec; 49(12):2171-2175. PubMed ID: 28425076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal gammopathy of undetermined significance versus smoldering myeloma: is active surveillance enough?
    Jordan WE; Emmons R; Vogl D; Morris GJ
    Semin Oncol; 2011 Jun; 38(3):327-34. PubMed ID: 21600358
    [No Abstract]   [Full Text] [Related]  

  • 11. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
    Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
    Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
    Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
    Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal gammopathy of ocular significance (MGOS) - a short survey of corneal manifestations and treatment outcomes.
    Garderet L; Al Hariri M; Wasielica-Poslednik J; Munder M; Kormányos K; Pena C; Gozzetti A; Zhou X; Waszczuk-Gajda A; Rosinol L; Mikala G; Krzystanski M; Lisch W; Vesole D; Szentmáry N; Jurczyszyn A
    Leuk Lymphoma; 2022 Apr; 63(4):984-990. PubMed ID: 34823428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance.
    Sprangers B; Hegenbart U; Wetzels JFM
    Transplantation; 2023 May; 107(5):1056-1068. PubMed ID: 36584374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies.
    Burgos L; Tamariz-Amador LE; Puig N; Cedena MT; Guerrero C; Jelínek T; Johnson S; Milani P; Cordon L; Perez JJ; Lasa M; Termini R; Oriol A; Hernandez MT; Palomera L; Martinez-Martinez R; de la Rubia J; de Arriba F; Rios R; Gonzalez ME; Gironella M; Cabañas V; Casanova M; Krsnik I; Perez-Montaña A; González-Calle V; Rodriguez-Otero P; Maisnar V; Hajek R; Van Rhee F; Jimenez-Zepeda V; Palladini G; Merlini G; Orfao A; de la Cruz J; Martinez-Lopez J; Lahuerta JJ; Rosiñol L; Blade J; Mateos MV; San-Miguel JF; Paiva B;
    J Clin Oncol; 2023 Jun; 41(16):3019-3031. PubMed ID: 36930848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perirenal fluid collections and monoclonal gammopathy.
    Viglietti D; Sverzut JM; Peraldi MN
    Nephrol Dial Transplant; 2012 Jan; 27(1):448-9. PubMed ID: 21810768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological characteristics and prognosis in patients with monoclonal gammopathy and renal damage in central China: a multicenter retrospective cohort study.
    He H; Wang Z; Xu J; Liu Y; Shao Y; Hou Y; Gu J; Hu R; Xing G
    Sci Rep; 2024 Apr; 14(1):7667. PubMed ID: 38561447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
    Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
    Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal gammopathy of renal significance: Early diagnosis is key.
    Alonso-Titos J; Martínez-Esteban MD; López V; León M; Martin-Reyes G; Ruiz-Esteban P; Hernández D
    Nefrologia (Engl Ed); 2021; 41(5):502-513. PubMed ID: 36165133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.